Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS4800 Tablets for Postoperative Dental Pain
CTR20220048Phase 2Completed
- Sponsor
- Hengrui Therapeutics
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-4800 in acute pain, sponsored by Hengrui Therapeutics. Started Jan 2022; status: completed.
02
Drugs
HRS-4800
03
Conditions
acute pain
Beyond the preview
Go deeper on CTR20220048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220048.